T-cell receptor-CD3-costimulatory signaling complex (TCR-CD3-costimulatory complex)

The T-cell receptor (TCR)-CD3-costimulatory signaling complex is the primary functional unit responsible for the recognition of antigens and the subsequent activation of T lymphocytes [2, 3]. It consists of the TCR heterodimer (alpha/beta or gamma/delta), which recognizes peptide-MHC complexes, and the non-covalently associated CD3 complex (epsilon, delta, gamma, and zeta chains) that transduces the signal into the cell via immunoreceptor tyrosine-based activation motifs (ITAMs) [3, 4]. Full T-cell activation typically requires a "second signal" provided by costimulatory molecules, most notably CD28, which interacts with B7 ligands on antigen-presenting cells to amplify TCR signaling and promote survival and proliferation [1, 5]. This complex is a central therapeutic target in oncology, where bispecific antibodies and CAR-T cells leverage its signaling machinery to redirect T-cell cytotoxicity against tumor cells [9, 10]. In autoimmune diseases and transplantation, modulation of the complex via costimulation blockade or anti-CD3 antibodies is used to suppress aberrant immune responses [5, 9]. Dysregulation of this signaling axis is implicated in various pathologies, including malignancies, chronic infections, and transplant rejection [2, 6]. Understanding the structural and functional dynamics of this integrated complex is essential for the design of next-generation immunotherapies [9, 10].

Other names

TCR-CD3-CD28 complexT-cell activation complexTCR/CD3 complexTCR-CD3-costimulatory complexImmunological synapse signaling complex

T-cell redirection, T-cell activation, T-cell depletion, costimulation blockade, and signal transduction modulation.